Kieran Murphy benoemd tot CEO van GE Healthcare, volgt John Flannery op
BOSTON–(BUSINESS WIRE)– Jeff Immelt, bestuursvoorzitter en CEO van GE, heeft vandaag bekendgemaakt dat Kieran Murphy per direct is benoemd tot president en CEO van GE Healthcare. Murphy is momenteel president en CEO van GE Healthcare Life Sciences. Hij is de opvolger van John Flannery, die onlangs is verkozen tot de nieuwe bestuursvoorzitter en CEO van GE.
Murphy, 54, is sinds september 2011 CEO van GE Healthcare Life Sciences. Onder zijn leiding steeg de omzet en groeide het bedrijf voor moleculaire geneeskunde in geografisch opzicht. Het GE-onderdeel is nu goed voor een jaaromzet van 4 miljard dollar en 11.000 werknemers in meer dan honderd landen. GE Healthcare Life Sciences levert uiteenlopende technologieën en diensten voor medicijnonderzoek, pre-klinische en klinische ontwikkeling en biofarmaceutische productie. Daarnaast levert het moleculaire middelen voor diagnostiek, selectie van de juiste therapie en toezicht op behandelingen.
Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery |
|||||
|
BOSTON–(BUSINESS WIRE)– GE Chairman and CEO Jeff Immelt announced today the appointment of Kieran Murphy as president and CEO of GE Healthcare, effective immediately. Murphy is currently president and CEO of GE Healthcare Life Sciences. Murphy succeeds John Flannery who has been appointed CEO and chairman elect of GE. Murphy, 54, was appointed CEO of GE Healthcare Life Sciences in September 2011. Since then, he has overseen significant revenue growth and geographic expansion of the molecular medicine business, which now accounts for more than $4 billion in annual sales with 11,000 employees in more than 100 countries. GE Healthcare Life Sciences provides a broad range of industry-leading technologies and services for drug discovery, pre-clinical and clinical development and biopharmaceutical manufacturing, as well as molecular tools for diagnostics, therapy selection and treatment monitoring in patient care. The business is a leader in organic growth, margins and cash generation. Immelt said: “In his career at GE, Kieran has demonstrated the right combination of talent and drive to step into this key leadership role at the company. Having led the strategic combination of GE’s Life Sciences and Medical Diagnostics units, Kieran is universally respected across GE and has distinguished himself as a strong customer advocate with great commercial instincts. Alongside the outstanding team at GE Healthcare, we anticipate that the business will experience continued global growth under Kieran’s leadership.” “Kieran has proven to be a natural leader and has been instrumental in the tremendous growth we’ve seen across GE Healthcare Life Sciences,” said Flannery. “I am confident that under his leadership the GE Healthcare team will continue to innovate and execute, introducing new products and driving cost productivity.” GE Healthcare, a $20 billion business, is the world’s leading manufacturer of medical imaging devices; life sciences tools to enable the next generation of biotherapeutics; medical diagnostic agents that enable personalized medicine; and healthcare IT and software tools to digitize and industrialize the healthcare industry. Healthcare is a key GE business now and in the future. Murphy joined GE Healthcare in 2008 from Whatman plc, a global supplier of filters and membranes for laboratory research, life sciences and medical diagnostic applications. He has over 20 years’ experience in the global life sciences and biotechnology industry, beginning his career with Janssen Pharmaceutical, a division of Johnson and Johnson, followed by leadership roles with Mallinckrodt, veterinary medicines provider Vericore, Novartis, Adprotech, ML Laboratories and Innovata plc. Having earned his bachelor’s degree in 1984 from University College, Dublin, he subsequently graduated from the University of Manchester Institute of Science and Technology with a master’s degree in Marketing. Ends About GE GE is the world’s Digital Industrial Company, transforming industry with software-defined machines and solutions that are connected, responsive and predictive. GE is organized around a global exchange of knowledge, the “GE Store,” through which each business shares and accesses the same technology, markets, structure and intellect. Each invention further fuels innovation and application across our industrial sectors. With people, services, technology and scale, GE delivers better outcomes for customers by speaking the language of industry.www.ge.com About GE Healthcare GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter – great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients. For more information about GE Healthcare, visit our website at www.gehealthcare.com. View source version on businesswire.com: http://www.businesswire.com/news/home/20170612005521/en/ Contacts GE Healthcare |
|||||